Research
& Impact

We fund the top 1% of the brightest new research
projects across every cancer to save and change
millions of lives.
Image banner of Marlene Hao with colourful dots

Your impact

We have been backing pioneering cancer research since 1967.

Thanks to you, we’ve kick-started more than 550 new ideas that have broken new ground to save lives.

Many of the talented emerging scientists whom we funded have had global breakthroughs and are now global leaders in cancer research.

Together, we will go even further to find the most impactful cures for cancer as quickly as we can.

Our researcher successes

Our 2024 researchers

Dr Taskeen Janjua

Cancer Type: Brain cancer

Research: Utilising ultrasmall nanoparticles to enable improved delivery of chemotherapy for glioblastoma brain tumours

Dr Zhian Chen

Cancer Type: Lung cancer

Research: Engineering next-generation immunotherapies for lung cancer patients

In the media

Dr Kulasinghe named Researcher of the Year

The Media Store is appointed to new pro bono client

Cure Cancer opens early-career research grant applications for 2023

Lunch & Learn series

Find out about the latest developments in cancer research first-hand from our researchers and the impact of your support.

We take on every cancer

Cure Cancer funds groundbreaking research across every cancer, no matter the size or rarity.

We aim to maximise our impact, save millions of lives, and leave no one behind.

Blood cancer
Bone cancer
Brain cancer
Breast cancer
Childhood cancer
Gastro-intestinal cancer
Gynaecological cancer
Prostate cancer

Our research grant program

We are dedicated to funding new innovative cancer research projects, giving talented emerging cancer researchers the opportunity to pursue their innovative ideas across diverse areas of cancer research.

Through our Research Grants Program, we commit to back new ideas from the most brilliant minds in cancer research.

Let's stay in touch

To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter.